Anavex Life Sciences Corp - Company Profile
Powered by 
All the sales intelligence you need on Anavex Life Sciences Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Anavex Life Sciences Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Anavex Life Sciences Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Anavex Life Sciences Corp (Anavex) that focuses on the discovery and development of novel drugs for the treatment of neurological diseases and cancer. The company's lead product: Anavex2-73 and sigmaceptor technology platform are its major strengths, while history of operating losses could be a cause for concern. The company could benefit from orphan drug designation, growing incidence of Alzheimer’s disease in the US, and market potential: CNS therapies. Nevertheless, its performance could be affected by uncertain R&D outcomes, government regulations and competitive environment.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer